Daniel Slade

500 total citations
23 papers, 185 citations indexed

About

Daniel Slade is a scholar working on Hematology, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniel Slade has authored 23 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Surgery and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniel Slade's work include Chronic Myeloid Leukemia Treatments (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Statistical Methods in Clinical Trials (3 papers). Daniel Slade is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Statistical Methods in Clinical Trials (3 papers). Daniel Slade collaborates with scholars based in United Kingdom, United States and Germany. Daniel Slade's co-authors include Kristian Brock, Elizabeth Ryan, Christina Yap, Simon Gates, Charles Craddock, Paul Ferguson, Andrea Hodgkinson, Mike Dennis, Francis Mussai and Rachel Wheat and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Daniel Slade

22 papers receiving 173 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Slade United Kingdom 8 79 36 29 29 28 23 185
Michael J. Martens United States 9 126 1.6× 18 0.5× 30 1.0× 37 1.3× 15 0.5× 30 193
Mona Shafey Canada 9 107 1.4× 45 1.3× 13 0.4× 43 1.5× 4 0.1× 36 245
Pawinee Kupatawintu Thailand 10 178 2.3× 70 1.9× 29 1.0× 13 0.4× 8 0.3× 34 307
Anthony Oyekunle Nigeria 11 192 2.4× 112 3.1× 17 0.6× 54 1.9× 2 0.1× 33 295
J Janssen Netherlands 7 105 1.3× 30 0.8× 83 2.9× 20 0.7× 3 0.1× 14 327
Matthew Turner United States 11 118 1.5× 28 0.8× 7 0.2× 17 0.6× 10 0.4× 24 355
Bruno Deltreggia Benites Brazil 9 110 1.4× 104 2.9× 66 2.3× 10 0.3× 3 0.1× 40 237
Jeff Schriber United States 4 228 2.9× 30 0.8× 31 1.1× 89 3.1× 2 0.1× 5 321
M.-J. Zhang United States 7 220 2.8× 44 1.2× 14 0.5× 84 2.9× 17 0.6× 10 292
Enrico Tendi Italy 11 153 1.9× 33 0.9× 41 1.4× 10 0.3× 26 0.9× 23 345

Countries citing papers authored by Daniel Slade

Since Specialization
Citations

This map shows the geographic impact of Daniel Slade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Slade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Slade more than expected).

Fields of papers citing papers by Daniel Slade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Slade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Slade. The network helps show where Daniel Slade may publish in the future.

Co-authorship network of co-authors of Daniel Slade

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Slade. A scholar is included among the top collaborators of Daniel Slade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Slade. Daniel Slade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sweeting, Michael, Daniel Slade, Dan Jackson, & Kristian Brock. (2025). Potential outcome simulation for efficient head-to-head comparison of adaptive dose-finding designs. Biometrics. 81(1).
2.
Patel, Amit, Kristian Brock, Daniel Slade, et al.. (2024). Implementing the time-to-event continual reassessment method in the presence of partial orders in a phase I head and neck cancer trial. BMC Medical Research Methodology. 24(1). 11–11. 2 indexed citations
3.
Chen, Yung‐Yi, Anna Rowe, Victoria Homer, et al.. (2022). Monoclonal antibody BTT1023 targeting vascular adhesion protein 1 for treating primary sclerosing cholangitis: BUTEO single-arm Phase II trial. SHILAP Revista de lepidopterología. 9(1). 1–54. 3 indexed citations
4.
5.
Veenith, Tonny, Benjamin A. Fisher, Daniel Slade, et al.. (2021). CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults. BMJ Open. 11(11). e050202–e050202. 3 indexed citations
6.
7.
8.
Ryan, Elizabeth, Kristian Brock, Simon Gates, & Daniel Slade. (2020). Do we need to adjust for interim analyses in a Bayesian adaptive trial design?. BMC Medical Research Methodology. 20(1). 150–150. 27 indexed citations
9.
Yap, Jason, Daniel Slade, William O. Dawson, et al.. (2020). Sinecatechins ointment as a potential novel treatment for usual type vulval intraepithelial neoplasia: a single‐centre double‐blind randomised control study. BJOG An International Journal of Obstetrics & Gynaecology. 128(6). 1047–1055. 9 indexed citations
10.
Thomas, Sophie, Jennifer Limond, Mathilde Chevignard, et al.. (2019). The European Society of Paediatric Oncology Ependymoma-II program Core-Plus model: Development and initial implementation of a cognitive test protocol for an international brain tumour trial. European Journal of Paediatric Neurology. 23(4). 560–570. 5 indexed citations
11.
Yap, Christina, et al.. (2019). Dose Transition Pathways for Continual Reassessment Method [R package dtpcrm version 0.1.1]. 1 indexed citations
12.
Copland, Mhairi, Daniel Slade, Jenny Byrne, et al.. (2019). FLAG-IDA and Ponatinib in Patients with Blast Phase Chronic Myeloid Leukaemia: Results from the Phase I/II UK Trials Acceleration Programme Matchpoint Trial. Blood. 134(Supplement_1). 497–497. 14 indexed citations
13.
14.
Slade, Daniel, et al.. (2018). How to transform infrastructure decision making in the UK. 2 indexed citations
15.
Slade, Daniel & Nicholas G. Davies. (2017). How to design an infrastructure strategy for the UK. 1 indexed citations
16.
Heller, Michael, et al.. (2015). Performance of an expedited rhythm control method for recent onset atrial fibrillation in a community hospital. The American Journal of Emergency Medicine. 33(7). 957–962. 7 indexed citations
17.
Alagiri, Madhu, et al.. (1998). Interstitial Cystitis: Unexplained Associations With Other Chronic Disease and Pain Syndromes. The Journal of Urology. 159(6). 2250–2251. 7 indexed citations
18.
Slade, Daniel. (1963). A CLINICAL TRIAL OF NALIDIXIC ACID (NEGRAM, WIN. 18,320) IN THIRTY‐THREE PATIENTS WITH URINARY INFECTIONS TREATED IN GENERAL PRACTICE. British Journal of Urology. 35(2). 125–128. 11 indexed citations
19.
Willson‐Pepper, J. K. & Daniel Slade. (1955). CALCIFICATION IN A POLYCYSTIC KIDNEY. British Journal of Urology. 27(2). 172–176. 3 indexed citations
20.
Slade, Daniel. (1952). FATAL POISONING IN CHILDREN FROM ASPIRIN, QUININE, AND ANTHISAN. The Lancet. 260(6739). 809–810. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. Martens Breakdown of academic impact, for papers by Mona Shafey Breakdown of academic impact, for papers by Pawinee Kupatawintu Breakdown of academic impact, for papers by Anthony Oyekunle Breakdown of academic impact, for papers by J Janssen Breakdown of academic impact, for papers by Matthew Turner Breakdown of academic impact, for papers by Bruno Deltreggia Benites Breakdown of academic impact, for papers by Jeff Schriber Breakdown of academic impact, for papers by M.-J. Zhang Breakdown of academic impact, for papers by Enrico Tendi
Rankless by CCL
2026